Published on : Aug 28, 2019
With the rising cases of people suffering from diabetes and obesity, there are many other complications that arise, among which the increased triglyceride levels is currently making rounds among the American Heart Association (AHA). The association is focusing majorly on this aspect and working on overcoming it.
Looking at this, new research suggests that prescription medicines containing omega-3 fatty acids might have cardiovascular benefits.
Triglycerides are the fats found in the blood. The liver produces some of it, whereas the other types of triglycerides are found in calories which are stored by the body to utilize later. More the calories consumed by a person, higher are the chances of having increased triglyceride levels.
Any amount over 200 milligrams per deciliter (mg/dl) is considered as higher for triglycerides. It increases the risk of heart attack or a stroke in an individual as it narrows the arteries. A study suggests that nearly one-fourth of the overall population in the US have their triglycerides levels more than 150 mg/dl. When the triglycerides level reaches above 500 mg/dl, it owns a high risk of developing pancreatitis.
A Few Methods Can be Helpful in bringing Down High Triglycerides Levels
However, there are certain methods to decrease levels of triglyceride. Some of them include decreasing alcohol consumption, reducing sugar intake and refined carbs, and regular workout. This helps in controlling the weight. One can also try to swap saturated fats with unsaturated fats.
But, these changes are sometimes not sufficient to make a significant difference. In such cases, medical experts need to rule out other conditions like hypothyroidism and type 2 diabetes before advising medication for increased triglyceride levels.
At present, two triglyceride-reducing medicines exist, where both of them contain omega-3 fatty acids. One consists of eicosapentaenoic acid (EPA), a fatty acid. The other consists of a combination of another fatty acid, named docosahexaenoic acid (DHA) and EPA. These medicines are assumed to be equally effective by AHA, in its recent review published in journal Circulation.